MILLENNIUM PHARMACEUTICALS has a total of 36 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Czechia, Hungary and Poland. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are DU PONT PHARM CO, BISACCHI GREGORY S and SANOFI ELF.
# | Country | Total Patents | |
---|---|---|---|
#1 | Czechia | 9 | |
#2 | Hungary | 5 | |
#3 | Poland | 5 | |
#4 | Taiwan | 4 | |
#5 | United States | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Australia | 2 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Croatia | 1 | |
#10 | Netherlands | 1 | |
#11 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Scarborough Robert M | 7 |
#2 | Luly Jay R | 5 |
#3 | Carson Kenneth G | 5 |
#4 | Harriman Geraldine C B | 5 |
#5 | Ghosh Shomir | 5 |
#6 | Pandey Anjali | 4 |
#7 | Zhu Bing-Yan | 4 |
#8 | Elder Amy M | 4 |
#9 | Song Yonghong | 4 |
#10 | Huang Wenrong | 4 |
Publication | Filing date | Title |
---|---|---|
TW201700482A | Proteasome inhibitors | |
PL376156A1 | Pgd2 receptor antagonists for the treatment of inflammatory diseases | |
HU0700720D0 | Chemokine receptor antagonist and the ir use | |
US2002170089A1 | Nucleic acids encoding defense inducible proteins and uses thereof | |
AU4172401A | 46867 transferase family members and uses therefor | |
CZ20002136A3 | Essential bacterial genes and use thereof | |
CZ20002465A3 | Essential bacterial genes and use thereof |